Published in AIDS Weekly, February 5th, 2001
M.M. Lederman and colleagues at the University Hospital in Cleveland, Ohio, performed a study to "to characterize early and later indices of cellular restoration among HIV-1 infected persons treated with abacavir and one protease inhibitor and...identify predictors of CD4 cell increases."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.